Thank you for taking the time to share your story with us.

We understand it may not always be easy to tell if your account is best suited to Module 7 or a later module. If you have any questions, please do not hesitate to contact a member of our team by emailing: covidinquiry@broudiejacksoncanter.co.uk or by calling us on our Freephone 0808 296 5839.

As a reminder, Module 7 (Test, Trace, and Isolate) will consider the policies and strategies developed and deployed to support the test, trace and isolate system by the UK Government and the Devolved Administrations.

It will consider the decisions made by key bodies, other options or technologies that were available and factors that may have influenced public compliance. You can read the draft provisional outline of scope for Module 7 here.

We cannot guarantee who (if anyone) the Chair may call to give evidence in oral hearings. We have been pushing to have as many of our clients' voices heard as possible and will continue to do so in this module.

Case references start with a letter e.g. A123456.001

Part 1: Do you believe your experiences of loss during the pandemic were connected to any of the below key issues we have identified?

Do you believe your experiences of loss during the pandemic were connected to any of the below key issues we have identified? If yes, please tick all that apply (optional). (optional)
Do you believe your experiences of loss during the pandemic were connected to any of the below key issues we have identified? If yes, please tick all that apply (optional) (optional)

Part 2: Share your Story and your Loved One’s Story

Part Two: Share your Story and your Loved One’s Story

Please tick all boxes that apply (optional)

Please tick all boxes that apply (optional)

1. Do you believe you or your loved one received enough financial and practical support to facilitate isolation? (optional)

1. Do you believe you or your loved one received enough financial and practical support to facilitate isolation? 

2. Do you believe that you or your loved one received clear messaging from the government regarding TTI procedures? (optional)

2. Do you believe that you or your loved one received clear messaging from the government regarding TTI procedures?

3. Do you believe that you or your loved one suffered unequal impacts of TTI policies and strategies due to any of the below characteristics / vulnerabilities? (optional)

3. Do you believe that you or your loved one suffered unequal impacts of TTI policies and strategies due to any of the below characteristics / vulnerabilities? 

4. Do you feel that Non-pharmaceutical interventions such as lockdowns, mask wearing, social distancing, and isolation slowed/stopped the spread of Covid-19? (optional)

4. Do you feel that Non-pharmaceutical interventions such as lockdowns, mask wearing, social distancing, and isolation slowed/stopped the spread of Covid-19?

Please use this box to draft your account or elaborate on your responses in Part 1 (optional)

Part 3: The Following Questions Relate to your Story and your Willingness to be a Witness in Module 7

Part 3: The Following Questions Relate to your Story and your Willingness to be a Witness in Module 7

Please tick all boxes that apply (optional)
Have you participated in the Inquiry’s Every Story Matters campaign or taken part in the Inquiry impact videos? (optional)

Have you participated in the Inquiry’s Every Story Matters campaign or taken part in the Inquiry impact videos?

If the Chair permits it, would you be willing to give oral evidence during Module 7 evidential hearings in Spring 2025? (optional)

If the Chair permits it, would you be willing to give oral evidence during Module 7 evidential hearings in Spring 2025?

Thank you for sharing your account with us. Your response will be reviewed by a member of our team in due course. Should we need any further information from you we will contact you. If you have completed this survey for our team to review, please click submit.
Thank you for sharing your account with us. Your response will be reviewed by a member of our team in due course. Should we need any further information from you we will contact you.  If you have completed this survey for our team to review, please click submit.